M. Sakai

Pharmacokinetic and Pharmacodynamic Profiles of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus and Moderate Renal Impairment

N. Inagaki, K. Furihata, K. Kondo, 2014, Clinical Drug Investigation.